Try searching for...
Dr Belinda Kiely
BSc(Med) MBBS FRACP PhD
For patients/carers
For doctors
BSc(Med) MBBS FRACP PhD
Locations
Clinical interests
- Breast cancer
Languages
Fluent
- English
Biography
Dr Kiely specialises in the treatment of people with breast cancer and is interested in clinical research to improve the symptoms and side effects of cancer and cancer treatment.
Dr Kiely is a medical oncologist with over 15 years of clinical experience. She is a senior lecturer at the University of Sydney, with clinical appointments at Campbelltown Hospital and Concord Hospital in Sydney.
Dr Kiely completed a fellowship in breast cancer and cancer genetics at Peter MacCallum Cancer Centre in Melbourne and a PhD at the University of Sydney. Her thesis was titled, “Estimating and communicating prognosis in advanced cancer”.
Dr Kiely specialises in the treatment of people with breast cancer and is interested in clinical research to improve the symptoms and side effects of cancer and cancer treatment. She supervises PhD students and is a supervisor and mentor for medical oncology trainees and medical students.
Dr Kiely was a member of the Advanced Breast Cancer International Consensus panel in 2019 and 2023 to develop the guidelines for the management of advanced breast cancer.
More information
Dr Kiely’s research focuses on breast cancer treatment, prognostication and survivorship. She has a keen interest in the management of menopausal symptoms in women with breast cancer.
- Medical Oncology Group of Australia
- American Society of Clinical Oncology
- Breast Cancer Trials (BCT)
- Breast Cancer Network Australia (BCNA) Strategic Advisory Group
- Advanced Breast Cancer Global Alliance
- Cardoso F, Paluch-Shimon S, Schumacher-Wulf E,.……, Kiely B, et al. 6th and 7th International Consensus Guidelines for the management of advanced breast cancer (ABC Guidelines 6 and 7). Breast. 2024 Aug;76:103756. doi: 10.1016/j.breast.2024.103756. Epub 2024 May 28. PMID: 38896983; PMCID: PMC11231614.
- Kiely BE, Liang R, Jang C, Magraith K. Safety of vaginal oestrogens for genitourinary symptoms in women with breast cancer. Australian Journal of General Practice, 2024. 53(5), 305–310. https://search.informit.org/doi/10.3316/informit.T2024050700000801895909175
- Lord SJ, Kiely BE, O'Connell DL, Daniels B, Beith J, Smith AL, Pearson SA, Chiew KL, Bulsara MK, Houssami N. Characteristics and post-metastasis survival of recurrent metastatic breast cancer over time–An Australian population-based record linkage study, 2001-2016. European Journal of Cancer. 2023 Dec 2:113468. https://doi.org/10.1016/j.ejca.2023.113468
- Nahm SH, Martin AJ, Clayton JM,…..Kiely BE. Accuracy of oncologists’ estimates of expected survival time in advanced cancer, JNCI Cancer Spectrum, Volume 7, Issue 6, December 2023, pkad094, https://doi.org/10.1093/jncics/pkad094
- Nahm SH, Stockler MR, Martin AJ, Grimison P, Fox P, Zielinski R, Hawson GAT, Tattersall MHN, Kiely BE. Using three scenarios to explain life expectancy in advanced cancer: attitudes of patients, family members, and other healthcare professionals. Support Care Cancer 30, 7763–7772 (2022). https://doi.org/10.1007/s00520-022-07167-3
